Cytel

Cytel is the world’s leading data-science CRO, driving advancements in human health through robust analytics and innovative clinical trial software. For nearly four decades, we have set the standard in adaptive trial design, leveraging extensive data insights to inform strategy throughout every phase of drug development and commercialization. Our mission is clear: accelerate drug development, enhance success rates, and deliver better patient outcomes. With a comprehensive suite of services from innovative trial design to end-to-end biometrics and real-world evidence, our specialized, multidisciplinary team ensures optimal strategies for preclinical research, trial execution, market access, and reimbursement. Headquartered in Cambridge, Massachusetts, Cytel has a global presence with over 2,000 employees across North America, Europe, and Asia. Learn more about how Cytel is harnessing the power of data to advance human health at www.cytel.com.

Sumitomo Pharma America, Inc.

Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html

takeda oncology

Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. At Takeda, we are united by our aspiration to cure cancer. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in the lives of people living with cancer. Our research and development efforts are focused on advancing medicines for thoracic, gastrointestinal and hematologic cancers by leveraging modalities best suited to treat these diseases. Our in-house expertise and innovation are complemented by our valued partners. We fuel these relationships with respect, scientific rigor and a shared commitment to address the most urgent needs of patients. Our diverse global team fosters an inclusive environment where employees are welcomed, empowered, and inspired. We are committed to ensuring that patients globally can benefit from and access our portfolio of medicines, while also progressing a pipeline of potential treatments for the future. For more information, visit www.takedaoncology.com. If you are interested in learning more about current career opportunities, please visit the Takeda Pharmaceuticals Career Page. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/

Colorcon®

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, core excipients, and functional packaging for the pharmaceutical industry. At Colorcon, our science-based approach to product development drives our innovation. Our people-centric approach to customers and partners elevates it all. Learn more at www.colorcon.com.

greenwich biosciences

Greenwich Biosciences is now part of Jazz Pharmaceuticals. Follow us at https://www.linkedin.com/company/jazz-pharmaceuticals